Dec 17, 2012
By:
Amy Ritter, PhD
Pfizer has agreed to pay $55 million plus interest to settle charges that Wyeth (acquired by Pfizer in October, 2009) improperly promoted the drug Protonix (pantoprazole).
|
Dec 10, 2012
By:
Amy Ritter, PhD
Biogen Idec and Isis Pharmaceuticals announced that they have entered into a global collaboration agreement under which the companies will discover and develop antisense drugs against three undisclosed targets to treat neurological or neuromuscular disorders.
|
Dec 3, 2012
By:
Amy Ritter, PhD
Eli Lilly released its annual report containing updates on progress and new initiatives in corporate responsibility.
|
Results from the 2012 employment survey.
Dec 1, 2012
By:
Amy Ritter, PhD
Results from the 2012 employment survey.
|
Recent research examines the sequence of events underlying cellular reprogramming, which may aid in better control of the production of induced pluripotent stem cells.
Dec 1, 2012
By:
Amy Ritter, PhD
Recent research examines the sequence of events underlying cellular reprogramming, which may aid in better control of the production of induced pluripotent stem cells.
|
Nov 26, 2012
By:
Amy Ritter, PhD
Novartis announced that it has received FDA approval for a seasonal influenza vaccine produced in cell culture, the first seasonal vaccine produced by this method to be approved in the US.
|
Nov 20, 2012
By:
Amy Ritter, PhD
FDA announced the availability of the guidance, “Q11 Development and Manufacture of Drug Substances,†in the Nov. 20, 2011 edition of the Federal Register.
|
Nov 19, 2012
By:
Amy Ritter, PhD
House Democrats have requested the Government Accountability Office (GAO) to conduct an inquiry into factors leading to an increased reliance on compounded products.
|
Nov 12, 2012
By:
Amy Ritter, PhD
An operation spanning 16 African countries and conducted by the World Customs Organization (WCO) in partnership with the Institute of Research against Counterfeit Medicines (IRACM) led to the seizure of more than 82 million doses of counterfeit medicines.
|
|
